Results 141 to 150 of about 14,737,518 (270)

ANTI-HTLV-I p19 SUPPRESSES HTLV-I AG EXPRESSION IN PERIPHERAL BLOOD LYMPHOCYTES FROM HTLV-I CARRJERS

open access: yesANTI-HTLV-I p19 SUPPRESSES HTLV-I AG EXPRESSION IN PERIPHERAL BLOOD LYMPHOCYTES FROM HTLV-I CARRJERS
Anti-HTLV-I antibodies possess an inhibitory action for HTLV-I infection. In cases where cells persistently expressing HTLV-I antigen are the source of infection m an in vitro system, antibodies against HTLV-I env antigens (such as anti-HTLV-I gp46 175-199 antibody, etc.) have an inhibitory action for HTLV-I cell to cell infection.
openaire  

Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1986
A. Rossi   +6 more
semanticscholar   +1 more source

Emerging virus coinfections of the CNS: HTLV I/II as a common denominator [PDF]

open access: yes, 2014
Christina Sklavou   +7 more
core   +1 more source

HIV/HTLV-1/2 Co-Infection in the Peruvian Amazon: Prevalence and Associated Factors. [PDF]

open access: yesViruses
Alava-Flores WG   +4 more
europepmc   +1 more source

Epidemiology and Clinical Outcomes of HTLV-1: A Comprehensive Narrative Review of Endemic and Nonendemic Regions. [PDF]

open access: yesCan J Infect Dis Med Microbiol
Noori B   +5 more
europepmc   +1 more source

Clinical outcomes-dependent IgG epitope profiling in HTLV-1 reveals differential recognition of pathogen-derived antigens. [PDF]

open access: yesFront Immunol
Cilento NE   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy